stocks logo

AXGN Valuation

AxoGen Inc
$
11.570
-0.190(-1.620%)
  • Overview
  • Forecast
  • Valuation

AXGN Relative Valuation

AXGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AXGN is overvalued; if below, it's undervalued.

Historical Valuation

No Data

Competitors Valuation Multiple

The average P/S ratio for AXGN's competitors is 2.80, providing a benchmark for relative valuation. AxoGen Inc Corp (AXGN) exhibits a P/S ratio of 2.39, which is -14.52% above the industry average. Given its robust revenue growth of 17.36%, this premium appears unsustainable.

FAQ

arrow icon

Is AxoGen Inc (AXGN) currently overvalued or undervalued?

AxoGen Inc (AXGN) is now in the Fair zone, suggesting that its current forward PS ratio of 2.39 is considered Fairly compared with the five-year average of 3.28. The fair price of AxoGen Inc (AXGN) is between 10.42 to 21.32 according to relative valuation methord.
arrow icon

What is AxoGen Inc (AXGN) fair value?

arrow icon

How does AXGN's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for AxoGen Inc (AXGN) as of May 20 2025?

arrow icon

What is the current FCF Yield for AxoGen Inc (AXGN) as of May 20 2025?

arrow icon

What is the current Forward P/E ratio for AxoGen Inc (AXGN) as of May 20 2025?

arrow icon

What is the current Forward P/S ratio for AxoGen Inc (AXGN) as of May 20 2025?